INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

LEGNLegend Biotech Corp

CIK 0001801198

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 5
Max Insider Score40
Connections11with evidence

LEGN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
SD
Sanders Corazon (Corsee) D.Director
LEGNLegend Biotech Corp
Open-market sale
SELL$259K
27.4K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Mao LiDirector · Sep 28, 2026
  • ← Insider ofevidence
    Salovey PeterDirector · Sep 28, 2026
  • ← Insider ofevidence
    Ji Darren XiaohuiDirector · Sep 28, 2026
17
SD
Sanders Corazon (Corsee) D.Director
LEGNLegend Biotech Corp
Grant or award
A
—
21.0K sh
Sep 24, 2026
Sep 28, 2026
traded Sep 24, 2026
+4d
SEC FORM 4

Evidence

17
ML
Mao LiDirector
LEGNLegend Biotech Corp
Grant or award
A—
21.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

21
HJ
Heyman Tomas J.Director
LEGNLegend Biotech Corp
Grant or award
A—
21.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

13
CJ
Casey Patrick JohnDirector
LEGNLegend Biotech Corp
Grant or award
A—
21.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

17
JX
Ji Darren XiaohuiDirector
LEGNLegend Biotech Corp
Grant or award
A—
28.3K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

21
SP
Salovey PeterDirector
LEGNLegend Biotech Corp
Grant or award
A—
28.3K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC FORM 4

Evidence

34
SE
Santos Carlos EChief Financial Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$50K
5,430 sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

9
SE
Santos Carlos EChief Financial Officer
LEGNLegend Biotech Corp
Grant or award
A—
19.7K sh
Sep 21, 2026Sep 23, 2026
traded Sep 21, 2026
+2dSEC FORM 4

Evidence

9
ZI
Zhang IngridChief Executive Officer
LEGNLegend Biotech Corp
Grant or award
A—
1.13M sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC FORM 4

Evidence

33
CJ
Casey Patrick JohnDirector
LEGNLegend Biotech Corp
Open-market sale
SELL$89K
6,000 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC FORM 4

Evidence

25
HY
Huang YingDirector, Chief Executive Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$82K
5,566 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

24
HY
Huang YingDirector, Chief Executive Officer
LEGNLegend Biotech Corp
Open-market sale
SELL$87K
9,936 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

← Insider ofevidence
Heyman Tomas J.
Director · Sep 28, 2026
  • ← Insider ofevidence
    Sanders Corazon (Corsee) D.Director · Sep 28, 2026
  • ← Insider ofevidence
    Santos Carlos EChief Financial Officer · Sep 23, 2026
  • ← Insider ofevidence
    Zhang IngridChief Executive Officer · Sep 16, 2026
  • ← Lobbied forevidence
    HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Casey Patrick JohnDirector · Jul 2, 2026
  • ← Insider ofevidence
    Huang YingDirector, Chief Executive Officer · Mar 27, 2026

    • Lobbying

    $180K reported · de-duplicated
    2026 Q2 $90K via firms2026 Q1 $90K via firms
    • HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)$90K2026 Q2 · posted Aug 26, 2026 · Health issues
    • HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)$90K2026 Q1 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.